Reviews/Ketogenic and Low Carb Diets/Raises LDL cholesterol in some individuals
Kw03 · KETO-CV-01 · v2
The evidence here consistently shows that some people see their LDL cholesterol climb after starting a ketogenic diet. A controlled feeding trial in young women found LDL rose in every participant [3], a survey of 548 adults mapped how widely the response varies and singled out a 'lean mass hyper-responder' subset [4], and a cohort of 17 patients saw very large rises that came back down when the diet stopped [12]. Multiple case reports and series describe dramatic individual spikes [1][2][6][7], while a 262-person diabetes cohort recorded a smaller average rise of about ten percent [15]. Because the claim only says a subset is affected, and because the rises reversed when people quit the diet, the evidence lands firmly in favour. What holds the panel slightly back is that much of the corpus is case material and several papers share the same authors.
A randomised crossover feeding trial found a ketogenic diet increased LDL cholesterol in every woman with a treatment effect of 1.82 mM, p<0.001 [3]. A survey of 548 adults documented markedly heterogeneous LDL responses and defined a lean-mass hyper-responder subgroup of 100 respondents [4], while a retrospective review of 17 patients found a mean LDL rise of 245% that fell again after the diet stopped [12]. Case reports and series describe extreme individual elevations, reaching 496 mg/dL [7] and 545-574 mg/dL [1][2], with cholesterol improving once the diet ceased [6]. A 262-person controlled cohort recorded a more modest +10% LDL (P=5.1e-5) [15], and an open-label pilot saw LDL rise by Day 140 (P<0.05) [9]. The contested point: The division is over how much weight the dramatic individual rises deserve: the corpus leans heavily on case reports and series [1][2][5][6][7][10][11], which capture striking subset responses but sit low on the evidence hierarchy. Mean-level effects range from large [12] to modest [15], and at least one KD trial reported cardiovascular risk factors as mostly favourable [16], so the direction of lipid change is not uniform across KD populations even where the subset rise is well documented.
All 18 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.
We’ll also send you other claims from Ketogenic and Low Carb Diets, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.
One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.
The corpus is dominated by case reports and case series ([1],[2],[5],[6],[7],[10],[11]) which are low on the evidence hierarchy and subject to selection and publication bias toward dramatic presentations.
Substantial author overlap (Norwitz/Feldman/Soto-Mota recur across [1],[2],[4],[5],[8]) weakens evidential independence for the LMHR-subset framing.
Where it remains uncertain. Much of the supporting evidence is case reports and series with substantial author overlap [1][2][4][5], and saturated-fat intake is an uncontrolled confounder [12], so the rise cannot always be attributed to carbohydrate restriction alone.
Aleatory
LDL response to carbohydrate restriction varies widely between people, from large elevations to reductions, so the subset affected and the magnitude are inherently variable [4].
Epistemic
Most supporting papers are case reports and series [1][2][5][6][7][10][11] rather than controlled trials, limiting what can be firmly known about the subset's size and generality.
Inferential
Observational and case material does not isolate carbohydrate restriction from saturated-fat intake, which [12] itself notes as a likely multifactorial contributor to the rise.
The load-bearing papers from a corpus of 18, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.
Randomised crossover trial giving direct causal evidence that a ketogenic diet raises LDL.
“The LCHF diet increased LDL cholesterol in every woman with a treatment effect of 1.82 mM ( p < 0.001).”
Panel auditInternal validity: high · scope of inference: Healthy, young, normal-weight women on a 4-week ketogenic LCHF feeding regimen.Key limitations: small sample · short duration · single sex and narrow population
Establishes the heterogeneous response and the existence of an elevation-prone subset (N=548).
“A subgroup of respondents with LDL cholesterol ≥200 mg/dL, HDL cholesterol ≥80 mg/dL, and TG ≤70 mg/dL were characterized as "lean mass hyper-responders."”
Panel auditInternal validity: low · scope of inference: Adults self-reporting carbohydrate-restricted diets; defines the lean mass hyper-responder subgroup.Key limitations: self-report survey · CRD broader than ketogenic · no randomization
Independent case series confirming KD-associated LDL rise and reversal.
“We present a case series of substantial increases in total cholesterol and low-density lipoprotein cholesterol following the initiation of a KD, with improvements in cholesterol levels once the KD was stopped.”
Panel auditInternal validity: low · scope of inference: Selected patients, particularly lean individuals, who had extreme lipid responses to a ketogenic diet.Key limitations: case series · selection on extreme response · no control
A single patient's LDL-C rose from 95 to 545 mg/dl after starting a ketogenic diet.
Panel auditInternal validity: low · scope of inference: One lean individual on a ketogenic diet for ulcerative colitis exhibiting the LMHR phenotype.Key limitations: n=1 · no control · self-selected case
4 of 18 papers shown. The full review lists all of them, with the panel’s arbitration →
Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.
Converging primary evidence including an RCT and a reversible cohort rise directly establishes KD-associated LDL elevation in a subset, with only design-hierarchy and independence caveats limiting it.
Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.
Assumptions that carry weight but are not themselves established.
The panel records the gap that would most move the claim, and the study that would close it.
Independent confirmation of the hyper-responder subset. Much subset evidence shares authors [1][2][4][5], so independent replication would strengthen the generality of the finding. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: A prospective, pre-registered cohort by an unaffiliated group measuring LDL response to a standardised ketogenic diet across a broad population.
Open question: What proportion of people starting a ketogenic diet experience a clinically marked LDL rise? Why it is still open: Subset data come from a web survey and clinic cohorts [4][12], not from a representative population sample.
Priors is a sceptical first reader, not peer review, and not medical advice.
Release 2026-q4 · graded 21 Oct 2026 · protocol v0.19